Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.14 - $695.9 $7,458 - $37.1 Million
-53,277 Reduced 76.6%
16,278 $2,000
Q3 2022

Nov 14, 2022

BUY
$0.5 - $523.8 $9,917 - $10.4 Million
19,835 Added 39.89%
69,555 $35,000
Q2 2022

Aug 15, 2022

BUY
$0.63 - $2.58 $6,460 - $26,455
10,254 Added 25.98%
49,720 $43,000
Q1 2022

May 16, 2022

SELL
$1.65 - $3.12 $19,146 - $36,204
-11,604 Reduced 22.72%
39,466 $99,000
Q4 2021

Feb 14, 2022

SELL
$2.31 - $5.85 $5,160 - $13,068
-2,234 Reduced 4.19%
51,070 $132,000
Q3 2021

Nov 15, 2021

SELL
$4.55 - $10.36 $818,940 - $1.86 Million
-179,987 Reduced 77.15%
53,304 $244,000
Q2 2021

Aug 11, 2021

SELL
$5.98 - $7.51 $358,871 - $450,690
-60,012 Reduced 20.46%
233,291 $1.61 Million
Q1 2021

May 17, 2021

BUY
$6.98 - $11.29 $1.48 Million - $2.39 Million
211,525 Added 258.66%
293,303 $2.15 Million
Q4 2020

Feb 16, 2021

BUY
$7.81 - $10.39 $305,183 - $405,999
39,076 Added 91.51%
81,778 $661,000
Q3 2020

Nov 16, 2020

BUY
$6.34 - $10.83 $20,402 - $34,850
3,218 Added 8.15%
42,702 $436,000
Q2 2020

Aug 14, 2020

BUY
$4.6 - $8.6 $75,407 - $140,979
16,393 Added 70.99%
39,484 $265,000
Q1 2020

May 15, 2020

SELL
$3.51 - $6.17 $138,441 - $243,357
-39,442 Reduced 63.07%
23,091 $105,000
Q4 2019

Feb 14, 2020

SELL
$5.76 - $7.35 $73,630 - $93,955
-12,783 Reduced 16.97%
62,533 $380,000
Q3 2019

Nov 14, 2019

BUY
$6.46 - $8.37 $486,541 - $630,394
75,316 New
75,316 $530,000

Others Institutions Holding RDHL

About RedHill Biopharma Ltd.


  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $562M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.